Literature DB >> 30513529

Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons.

Ales Bartos1,2, Dan Fayette3.   

Abstract

BACKGROUND: The Czech version of the Montreal Cognitive Assessment (MoCA-CZ) and delayed recall of 5 words have not been validated in patients with mild cognitive impairment (MCI) due to Alzheimer disease (AD) and compared to norms of a large population.
METHOD: The MoCA-CZ was administered to 1,600 elderly individuals in 2 groups consisting of 48 patients with MCI due to AD (AD-MCI) and 1,552 normal elderly adults.
RESULTS: MoCA-CZ scores were significantly lower in the AD-MCI patients than in the normal elderly (21 ± 4 vs. 26 ± 3 points; p = 0.03). Under the recommended cutoff score of ≤25, the MoCA-CZ demonstrated an excellent sensitivity of 94% but a low specificity of 62%. When the score was reduced to ≤24, the MoCA-CZ showed an optimal sensitivity of 87% for AD-MCI and a specificity of 72%. Normal elderly persons should recall at least 2 words after delay (sensitivity 80%, specificity 74%). Several cutoff points were derived from normative data stratified by age and education.
CONCLUSIONS: The cutoff for AD-MCI and stratified norms are available for the MoCA total score and delayed recall of the Czech version. The cut-off scores of the MoCA-CZ, sensitivity, and specificity are lower than in the original study.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Alzheimer disease; Cutoff; Dementia; Mild cognitive impairment; Montreal Cognitive Assessment; Norm; Screening; Validation

Mesh:

Year:  2018        PMID: 30513529     DOI: 10.1159/000494489

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  4 in total

1.  Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool.

Authors:  Ajda Novak; Karmen Vizjak; Albin Gacnik; Martin Rakusa
Journal:  Acta Neurol Belg       Date:  2022-08-04       Impact factor: 2.471

2.  Changes in Serum Amyloid A (SAA) and 8-OHdG in Patients with Senile Early Cognitive Impairment.

Authors:  Xiaohong Cao; Ping Chen
Journal:  Med Sci Monit       Date:  2020-02-01

Review 3.  Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review.

Authors:  Chian Thong Chun; Kirsty Seward; Amanda Patterson; Alice Melton; Lesley MacDonald-Wicks
Journal:  Nutrients       Date:  2021-11-08       Impact factor: 5.717

4.  Regression-Based Normative Data for the Montreal Cognitive Assessment (MoCA) and Its Memory Index Score (MoCA-MIS) for Individuals Aged 18-91.

Authors:  Roy P C Kessels; Nathalie R de Vent; Carolien J W H Bruijnen; Michelle G Jansen; Jos F M de Jonghe; Boukje A G Dijkstra; Joukje M Oosterman
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.